Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey Report
-
Published:2024-02-23
Issue:3
Volume:13
Page:198
-
ISSN:2076-0817
-
Container-title:Pathogens
-
language:en
-
Short-container-title:Pathogens
Author:
Matungala-Pafubel Mathy12, Bulabula-Penge Junior123, Matondo-Kuamfumu Meris12, Esala Samy4, Edidi-Atani François12, Pukuta-Simbu Elisabeth1, Tshiminyi-Munkamba Paul1, Tutu Tshia N’kasar Yannick5, Katanga Trésor4, Ndomba-Mukanya Etienne12ORCID, Mbonga-Mande Delphine1, Baketana-Kinzonzi Lionel1, Kinganda-Lusamaki Eddy12ORCID, Mukadi-Bamuleka Daniel12ORCID, Mambu-Mbika Fabrice12, Mbala-Kingebeni Placide12, Nkwembe-Ngabana Edith12, Nkuba-Ndaye Antoine12ORCID, Okitundu-Luwa Daniel6, Ahuka-Mundeke Steve12
Affiliation:
1. Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo 2. Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo 3. Département de Biologie Médicale, Université Protestante au Congo, Kinshasa 01212, Democratic Republic of the Congo 4. Division Provinciale de la Santé de Kinshasa, Kinshasa 01204, Democratic Republic of the Congo 5. Direction de Surveillance Epidémiologique de Kinshasa, Ministère de Santé, Hygiène et Prévention, Kinshasa 01204, Democratic Republic of the Congo 6. Centre Neuro-Psycho-Pathologie, Kinshasa H8V3+CJ3, Democratic Republic of the Congo
Abstract
Polio-associated paralysis is one of the diseases under national surveillance in the Democratic Republic of the Congo (DRC). Although it has become relatively rare due to control measures, non-polio paralysis cases are still reported and constitute a real problem, especially for etiological diagnosis, which is necessary for better management and response. From September 2022 to April 2023, we investigated acute flaccid paralysis (AFP) cases in Kinshasa following an alert from the Provincial Division of Health. All suspected cases and their close contacts were investigated and sampled. Among the 57 sampled patients, 21 (36.8%) were suspects, and 36 (63.2%) were contacts. We performed several etiological tests available in the laboratory, targeting viruses, including Poliovirus, Influenza virus, SARS-CoV-2, Enterovirus, and arboviruses. No virus material was detected, but the serological test (ELISA) detected antibodies against Chikungunya Virus, i.e., 47.4% (27/57) for IgM and 22.8% (13/57) for IgG. Among suspected cases, we detected 33.3% (7/21) with anti-Chikungunya IgM and 14.3% (3/21) of anti-Chikungunya IgG. These results highlight the importance of enhancing the epidemiological surveillance of Chikungunya.
Funder
Provincial Health Division in Kinshasa and the Institut National de Recherche Biomédicale
Reference20 articles.
1. Acute Flaccid Paralysis in Adults: Our Experience;Kaushik;J. Emerg. Trauma Shock,2014 2. Immunotherapy of Guillain-Barré Syndrome;Liu;Hum. Vaccines Immunother.,2018 3. Profil épidémiologique des paralysies flasques aiguës (PFA) de 2009 à 2018 en Guinée;Sawadogo;J. Interv. Epidemiol. Public Health,2021 4. Soumahoro, M.-K., Boelle, P.-Y., Gaüzere, B.-A., Atsou, K., Pelat, C., Lambert, B., La Ruche, G., Gastellu-Etchegorry, M., Renault, P., and Sarazin, M. (2011). The Chikungunya Epidemic on La Réunion Island in 2005–2006: A Cost-of-Illness Study. PLoS Negl. Trop. Dis., 5. 5. Surveillance virologique des paralysies flasques aiguës en République démocratique du Congo (RDC) 1997–2001;Kabue;Méd. Trop.,2004
|
|